ESC 365 - Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: the PCSK9-REACT study

ESC Premium Access

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: the PCSK9-REACT study

Session: Best Posters 5 - Best Posters in antiplatelet agents in acute coronary syndromes

Topic: Thrombosis and platelets

Speaker: Professor E. Navarese (Sassari, IT)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Eliano Pio Navarese

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari (Italy)

6 presentations

1 follower

4 more presentations in this session

Discussant: Best Posters in antiplatelet agents in acute coronary syndromes

Comparison of Prescription and Bleeding Rates and Clinical Outcomes of Contemporary P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Speaker: Assistant Professor J. Choe (Pusan, KR)

Ticagrelor- and prasugrel-mediated platelet inhibition is not affected by mild therapeutic hypothermia generated in vitro in patients with an acute myocardial infarction

Speaker: Doctor I. Buera Surribas (Barcelona, ES)

Influence of amlodipine on antiplatelet effect of clopidogrel in patients treated with percutaneous coronary intervention: result of the randomized, prospective, two-period, crossover, ACCEL-CCB trial

Speaker: Professor Y. Jeong (Gwangmyeong, KR)

Access the full session

Best Posters 5 - Best Posters in antiplatelet agents in acute coronary syndromes

Speakers: Professor E. Navarese, Assistant Professor J. Choe, Doctor I. Buera Surribas, Professor Y. Jeong

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources